Biomarkers for Therapeutic Advances in Breast Cancer
This special issue belongs to the section "Cellular Pathology".
Special Issue Information
Dear Colleagues,
Breast cancer is the second most common cancer in women. The role of novel biomarkers at the genomic, transcriptomic, proteomic, and immunologic levels in treatment decision making for breast cancer is increasing day by day. A deeper investigation of breast cancer-associated novel biomarkers could enhance treatment effectiveness and patient survival.
This Special Issue of Cells, entitled “Biomarkers for Therapeutic Advances in Breast Cancer”, aims to solicit contributions highlighting exciting new findings in the area of biomarkers and therapeutic strategies, together with advanced experimental approaches, for the management of breast cancer.
Authors are welcome to submit comprehensive review articles, original research studies, and communications of preliminary, but significant, experimental results. Each submitted manuscript will undergo a formal peer review process. Submitted manuscripts must not have been published previously, nor can they be under consideration for publication in other journals.
Dr. Nicola Fusco
Dr. Umberto Malapelle
Dr. Cristian Scatena
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the Special Issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- breast cancer
- biomarkers
- therapeutic strategies
- targeted therapy
- breast cancer management
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Related Special Issues
- Predictive Molecular Pathology in Breast CancerinCells (4 articles)

